Ovulation Induction: Clinical Trials

4 trials for Ovulation Induction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Terminated 2

Follow Ovulation Induction: new trials by email Literature Review of Ovulation Induction trials Research Report on Ovulation Induction

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Myo-inositol Versus Clomiphene Citrate in PCOS
Myo-inositol, Clomiphene Citrate - Ovulation Induction, Polycystic Ovary Syndrome
Phase 4TerminatedUniversity Hospital, Ghent122020-07-022022-12-21
Letrozole Versus Gonadotropins in Clomiphene Citrate Resistance
Letrozole 2.5mg, Gonadotropin - Clomiphene Citrate Resistance, Ovulation Induction
Phase 4CompletedTanta University702019-03-012021-04-08
Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction
Recombinant FSH (follitropin alpha) - Ovulation Induction
Phase 4CompletedMerck KGaA, Darmstadt, Germany3102009-03-012014-02-13
Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)
Mild stimulation - in Vitro Fertilization, Ovulation Induction
Phase 4TerminatedUMC Utrecht1472009-01-012019-01-29

Narrower conditions

Polycystic Ovary Syndrome (2)  ·  Infertility (1)

Broader conditions

Adnexal Diseases (2)  ·  Cysts (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Gonadal Disorders (2)  ·  Neoplasms (2)  ·  Ovarian Cysts (2)  ·  Ovarian Diseases (2)  ·  Urogenital Diseases (2)

Interventions

Clomiphene (1)  ·  Glycoprotein Hormones, alpha Subunit (1)  ·  Gonadotropins (1)  ·  Inositol (1)  ·  Letrozole (1)  ·  follitropin alfa (1)  ·  follitropin beta (1)  ·  ganirelix (1)

Sponsors

Merck KGaA, Darmstadt, Germany (1)  ·  Tanta University (1)  ·  UMC Utrecht (1)  ·  University Hospital, Ghent (1)

Countries

Belgium (2)  ·  Egypt (1)  ·  Kuwait (1)  ·  Lebanon (1)  ·  Netherlands (1)  ·  Saudi Arabia (1)

Top investigators

Ayman Dawood, MD (1)  ·  Bart C Fauser, Prof, PhD (1)  ·  Khaled Esmat, MD (1)

Results publications

PMID 24942155

NIH funding

2018 (1)